ASSESSING THE LEADER TRIAL: UNDERSTANDING MYOCARDIAL INFARCTION SUBTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS AND THE BENEFICIAL IMPACT OF LIRAGLUTIDE THERAPY.
Background: Myocardial infarction (MI), often associated with diabetes mellitus (DM), lacks detailed subtype data. Liraglutide, administered to high-risk Type 2 DM individuals, reduced major CV events, including CV mortality, non-fatal MI, and non-fatal stroke, based on the LEADER trial (8,240 p...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Student's Journal of Health Research
2023-12-01
|
| סדרה: | Student's Journal of Health Research Africa |
| נושאים: | |
| גישה מקוונת: | https://sjhresearchafrica.org/index.php/public-html/article/view/865 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|